Regulatory compliance - December 9, 2014
AstraZeneca Scores Victory in Pay-for-Delay Case
In what could become a significant decision for the pharmaceutical industry, a jury in U.S. federal court found that AstraZeneca’s deal with Ranbaxy Laboratories to settle a patent fight over its heartburn medication Nexium did not violate antitrust laws. A group of pharmacies, wholesalers and insurers had sued over the agreement. As Bloomberg reported, this is the […]
